Is the FDA licensing process subjective enough for a hostile FDA to fail us on the interim look, even if we pass statistically?
To some degree. For instance if the alpha assigned to the interim is 0.01 and Dendreon announces a p value of 0.0095 then there is reason for concern that the FDA will 'find' an error somewhere. (They might approve anyway - but it is far from certain)
OTOH if they get a p value of 0.001 on the interim vs an alpha of 0.01 then it is unlikely that Provenge would be rejected.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.